SPOTLIGHT -
Health literacy is the next frontier in effective delivery.
FDA Updates: Approvals in Rare Disorders; Expanded Approval for Flu Treatment
FDA approves several drugs to treat rare conditions in both cancer and metabolic diseases.
Read More
FDA Updates: Treatment for Duchenne Mutation, Gilead Seeks Remdesivir Approval, Data on ALKS 3831
Actions from FDA this week include approval of a second targted treatment for a Duchenne muscular dystrophy mutation, and filings in COVID-19 and blood disorders.
FDA Updates: Assays Used in Cancer Care Get Green Light
Adaptive Biotechnologies’ clonoSEQ gets third approval; FDA also acts on first at-home treatment for spinal muscular atrophy.
Hospital CEO Keeps Pediatric Care Local
This month’s featured exec is Deborah Feldman, president and CEO of Dayton Children’s Hospital. Here, she sheds light on how the future of healthcare is shaping up, and how value-based care, the ACA, and pediatric pain management fit in.
Medical science sure to help us live longer
Would you pay $19,900 to add another year to your life? If only it were that simple. The New England Journal of Medicine (NEJM) recently published a study that concluded between 1960 and 2000, we paid an average of $19,900 in medical costs per year of life gained during that time. In 1960, a newborn's life expectancy was 69.9 years, and in 2000, it was 76.87 years, according to the study.
Rural access route: E-health investments and network of support facilities help connect rural residents to high-quality care
Telemedicine programs decrease time-to-diagnosis, save financial resources and reduce hospital stays.
